Načítá se...
Apixaban to prevent stroke in patients with atrial fibrillation: a review
Atrial fibrillation is a common, costly and morbid cardiovascular arrhythmia. Stroke prevention remains the mainstay of treatment for atrial fibrillation, and the recent advent of novel oral anticoagulants with direct factor IIa or factor Xa inhibition has significantly revolutionized this aspect of...
Uloženo v:
| Vydáno v: | Ther Adv Cardiovasc Dis |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5942796/ https://ncbi.nlm.nih.gov/pubmed/27342651 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753944716652787 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|